Clinical Trials Browser

Terminated × Leukemia × Bone Marrow Transplantation × Clear all

Kidney Neoplasms, Leukemia, Lymphoma, Multiple Myeloma, Myelodysplastic Syndromes, Neoplasms, Plasma Cell

NCT00005984 2017-11-29

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

Phase 2 Terminated

22 enrolled

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase

NCT00066417 2013-05-01

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Phase 2 Terminated

51 enrolled

MyeloidOther hematologic neoplasm

Congenital Abnormalities, Blast Crisis, Leukemia, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00499889 2012-04-23

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

Phase 2 Terminated

42 enrolled 8 charts

MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical Trials

Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy

Cyclophosphamide and Filgrastim Followed By SCT in Patients With Chronic or Accelerated Phase Myelogenous Leukemia

Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia

Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients